Grifols (GRFS)
Create an Alert
26.47
-0.11 -0.41%
NASDAQ
Jun 18, 5:00PM
BATS Real time
Currency in USD
Grifols Retained Earnings Quarterly YoY Growth:
-87.23% for March 31, 2013Grifols Historical Retained Earnings Quarterly YoY Growth Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -87.23% |
| Dec. 31, 2012 | 421.8% |
| Sept. 30, 2012 | |
| June 30, 2012 | 13.06% |
About Retained Earnings Growth
Retained Earnings Growth is the percent increase/decrease of a company's retained net income over time. A company can use retained earnings to maintain current operations, or to invest in new ventures. Generally speaking, retained earnings growth is accompanied by subsequent increases in sales and profitability.
If a company's retained earnings at the end of 2008 were $12 million, and by the end of 2009 the company's retained earnings increased to $15 million, the company experienced a retained earnings growth of 25%.
Learn More
GRFS Retained Earnings Quarterly YoY Growth Benchmarks
| Companies | |
|---|---|
| Cadence Pharmaceuticals | |
| ARCA biopharma | |
| Clinuvel Pharmaceuticals |
GRFS Retained Earnings Quarterly YoY Growth Range, Past 5 Years
| Minimum | -87.23% | Mar 2013 |
| Maximum | 421.8% | Dec 2012 |
| Average | 115.9% |
